03181-A : Characterization of Canine CD39 and CD73 for Use in Regenerative Medicine

Grant Status: Open

Grant Amount: $18,932
Ronald Sluyter, PhD and Reece Andrew Sophocleous, PhD; University of Wollongong
August 1, 2023 - October 31, 2024

Sponsor(s):

Breed(s): -All Dogs
Research Program Area: Musculoskeletal Conditions and Disease
Donate to Support this Research Program Area

Abstract

The wellness of active dogs is greatly diminished by musculoskeletal diseases and conditions. These pathologies include osteoarthritis, degenerative joint disease and spinal cord disease. Regenerative medicine affords new opportunities to improve the wellness of dogs. The transplantation of mesenchymal stromal cells is an emerging therapy in regenerative medicine. These cells mediate their therapeutic effects, in part, through the action of cell-surface enzymes, termed CD39 and CD73, which help to improve regeneration of tissues through their regenerative properties. However, progress in this field in relation to dogs is undermined by the lack of validated reagents to and functional characterization of these enzymes, limiting the quality assurance of mesenchymal stromal cells derived from dog tissues for use as therapeutic cells.

Publication(s)

Ronald Sluyter, Tahnee B.-D. McEwan, Reece A. Sophocleous, Leanne Stokes, Methods for studying P2X4 receptor ion channels in immune cells, Journal of Immunological Methods, 2024,113626, ISSN 0022-1759, https://doi.org/10.1016/j.jim.2024.113626.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

  

© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.